Phase 3 Pancreatic Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are willing to take part voluntarily and able to follow the study requirements after signing a consent form
• You are between 18 and 75 years old (inclusive)
• You have been diagnosed with pancreatic cancer confirmed by a tissue or cell sample test
• Your pancreatic cancer has spread to other parts of the body (Stage IV / metastatic)
• You have not yet received any full-body (systemic) treatment for your metastatic pancreatic cancer
• You have at least one tumour that can be measured on a scan, according to standard criteria
• You are generally able to carry out daily activities with no or minimal limitations (confirm with trial site for exact fitness level required)
• You are expected to live for at least 12 weeks

Who may not be able to join:

• You have received certain immune-boosting or immune-modifying treatments in the 2 weeks before starting the trial
• You have had another type of cancer in the past 5 years
• You have had major surgery within 4 weeks before starting the trial
• You have had radiotherapy to relieve symptoms within 1 week, or more intensive radiotherapy within 4 weeks, before starting the trial
• You have a known allergy to any of the study drugs: surufatinib, camrelizumab, nab-paclitaxel, or gemcitabine
• You have taken certain medications that strongly affect how the liver processes drugs, within a specific time period before starting the trial (confirm with trial site)
• You have used immune-suppressing medications within 4 weeks before starting the trial
• You have a significant liver condition, such as active hepatitis or moderate to severe liver scarring (cirrhosis)
• You currently have high blood pressure that cannot be controlled with medication

Important: Always verify eligibility with the trial site directly before applying.